Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q2 2025 Earnings Conference Call January 2, 2025 4:00 PM ET
Company Participants
Stephanie Diaz – Manager, IR
Paul Josephs – President & CEO
Ryan Lake – CFO
Conference Call Participants
Matt Hewitt – Craig-Hallum Capital Group
Jacob Johnson – Stephens
Michael Petusky – Barrington Research
Operator
Good afternoon, and thank you for joining Lifecore’s Financial 2025 Second Quarter Earnings Call. During the call, all participants will be in a listen-only mode.
Now I would like to turn the call over to Stephanie Diaz, Manager of Investor Relations for Lifecore. Please go ahead.
Stephanie Diaz
Good afternoon, and thank you for joining us today to discuss Lifecore Biomedical’s second quarter fiscal 2025 earnings results. Hosting the call today from Lifecore are Paul Josephs, President and Chief Executive Officer; and Ryan Lake, Chief Financial Officer.
Before we begin today, we’d like to remind everyone that certain statements made in the course of this conference call contain forward-looking statements. It is important to note that the forward-looking statements made during this call reflect management’s judgment and analysis only as of today, January 2, 2025, and the company’s actual results could differ materially from those projected in such forward-looking statements.
For a more thorough discussion of the risks and uncertainties associated with any forward-looking statements, please see the disclaimer regarding forward-looking statements that is included in our fiscal 2025 second quarter earnings release, which was furnished to the SEC today on Form 8-K as well as our other filings with the Securities and Exchange Commission, including, but not limited to the company’s Form 10-Q for Q2 fiscal 2025, which was filed this afternoon.
With that, I’d like to turn the call over to Paul Josephs, Chief Executive Officer.
Paul Josephs
Thank you, Stephanie. Good afternoon, everyone, and thank you for joining our fiscal
Read the full article here